Axel Le Cesne, MD

Gustave Roussy Institute
Villejuif, Ile-de-France, France

Disclosure information not submitted.

Presentation(s):

• Paper 24 - MILADEMETAN VS. TRABECTEDIN IN PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: RESULTS FROM THE PHASE 3 MANTRA STUDY

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM  

• Paper 25 - PRELIMINARY RESULTS FROM A PHASE 1 STUDY OF FHD-609, A BROMODOMAIN-CONTAINING PROTEIN 9 DEGRADER, IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR SMARCB1-LOSS TUMORS

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM  

• Paper 30 - OUTCOMES OF PATIENTS WITH ADVANCED SYNOVIAL SARCOMA TREATED WITH AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")

  Friday, November 3, 2023
  9:00 AM – 10:00 AM